Insider Selling: Dolby Laboratories (NYSE:DLB) SVP Sells $426,382.92 in Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,666 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $55.62, for a total value of $426,382.92. Following the sale, the senior vice president directly owned 118,727 shares in the company, valued at $6,603,595.74. This represents a 6.07% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Dolby Laboratories Trading Down 0.6%

Dolby Laboratories stock opened at $53.70 on Friday. Dolby Laboratories has a twelve month low of $52.45 and a twelve month high of $77.00. The stock’s fifty day simple moving average is $58.97 and its 200-day simple moving average is $62.63. The firm has a market capitalization of $5.08 billion, a P/E ratio of 21.23 and a beta of 0.81.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. During the same quarter in the prior year, the company earned $1.34 earnings per share. The company’s revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts predict that Dolby Laboratories will post 3.21 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.7%. The ex-dividend date of this dividend was Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio is 56.92%.

Institutional Trading of Dolby Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in DLB. Royal Bank of Canada increased its position in shares of Dolby Laboratories by 3.5% during the first quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker’s stock worth $5,491,000 after purchasing an additional 2,298 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Dolby Laboratories by 218.8% during the first quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock worth $20,043,000 after purchasing an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Dolby Laboratories by 5.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker’s stock worth $19,131,000 after purchasing an additional 12,598 shares in the last quarter. Focus Partners Wealth acquired a new stake in shares of Dolby Laboratories during the first quarter worth about $390,000. Finally, EverSource Wealth Advisors LLC increased its position in shares of Dolby Laboratories by 273.3% during the second quarter. EverSource Wealth Advisors LLC now owns 2,598 shares of the electronics maker’s stock worth $193,000 after purchasing an additional 1,902 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on the company. Barrington Research restated an “outperform” rating and issued a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $90.75.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.